Severe Pancytopenia Following Single Dose Methotrexate In Psoriasis: A Rare And Potentially Lethal Manifestation

Curr Drug Saf. 2021;16(1):110-113. doi: 10.2174/1574886315666201026125149.

Abstract

Methotrexate is an anti-metabolite, anti-cancer drug frequently used in the treatment of extensive chronic plaque psoriasis. Psoriatic plaque erosion is a rare toxic side effect of single-dose methotrexate and is described as a sign of impending pancytopenia. Here, we report a case of a 48- year-old male presented with multiple oral and genital erosions, accompanied by fissuring over palm and soles for 5 days. His laboratory tests revealed severe pancytopenia and nephropathy. He had a history of chronic plaque psoriasis for which he took a single dose of 15 mg methotrexate. During the hospital stay, the patient needed folate antagonist, granulocyte colony-stimulating factor (G-CSF), intravenous fluids, blood transfusions, and platelet transfusions. He recovered within 12 days of admission.

Keywords: Psoriatic; acute methotrexate toxicity; blood transfusions; granulocyte colony stimulating factor; nephropathy; pancytopenia.

Publication types

  • Case Reports

MeSH terms

  • Humans
  • Male
  • Methotrexate / adverse effects
  • Middle Aged
  • Pancytopenia* / chemically induced
  • Pancytopenia* / diagnosis
  • Psoriasis* / diagnosis
  • Psoriasis* / drug therapy

Substances

  • Methotrexate